Skip to content
Screener

Shattuck Labs, Inc. STTK Operating Cash Flow

Operating Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
$10.69B+246%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
Amgen logo
AmgenAMGN
$4B+75.5%
AbbVie logo
AbbVieABBV
$3.83B+134%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$19.85M-98.6%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.99M-75.5%

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$694.34M+1,861%
Enterprise value$633.72M-5,344%
P/S694.3×+683×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Accounts payable1,613(1,944)
Accrued expenses and other current liabilities(1,162)(1,637)
Non-current operating lease liabilities216(490)
Net cash used in operating activities(23,609)(22,463)
Cash flows from investing activities:
Maturities of investments23,91415,600
Purchases of investments(144,871)
Purchase of property and equipment(141)

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s operating cash flow?
Shattuck Labs, Inc. (STTK) reported operating cash flow of -$10.19M in Q2 2026.
How has Shattuck Labs, Inc.'s operating cash flow changed year-over-year?
Shattuck Labs, Inc.'s operating cash flow increased by 2.4% year-over-year, from -$10.43M to -$10.19M.
What is the long-term trend for Shattuck Labs, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), Shattuck Labs, Inc.'s operating cash flow has grown at a -8.6% compound annual growth rate (CAGR), from -$57.12M to -$39.88M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Shattuck Labs, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude